Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lifecore Biomedical, Inc. \De\ (LFCR) Other Non-Current Assets (2016 - 2025)

Historic Other Non-Current Assets for Lifecore Biomedical, Inc. \De\ (LFCR) over the last 17 years, with Q2 2025 value amounting to $6.6 million.

  • Lifecore Biomedical, Inc. \De\'s Other Non-Current Assets rose 1578.95% to $6.6 million in Q2 2025 from the same period last year, while for May 2025 it was $6.6 million, marking a year-over-year increase of 1578.95%. This contributed to the annual value of $6.6 million for FY2025, which is 1578.95% up from last year.
  • Lifecore Biomedical, Inc. \De\'s Other Non-Current Assets amounted to $6.6 million in Q2 2025, which was up 1578.95% from $4.9 million recorded in Q1 2025.
  • In the past 5 years, Lifecore Biomedical, Inc. \De\'s Other Non-Current Assets ranged from a high of $170.4 million in Q1 2021 and a low of $2.6 million during Q4 2024
  • Moreover, its 5-year median value for Other Non-Current Assets was $6.1 million (2023), whereas its average is $48.2 million.
  • Per our database at Business Quant, Lifecore Biomedical, Inc. \De\'s Other Non-Current Assets surged by 832060.28% in 2021 and then plummeted by 9257.95% in 2023.
  • Lifecore Biomedical, Inc. \De\'s Other Non-Current Assets (Quarter) stood at $133.2 million in 2021, then crashed by 65.78% to $45.6 million in 2022, then plummeted by 91.07% to $4.1 million in 2023, then tumbled by 36.96% to $2.6 million in 2024, then skyrocketed by 156.25% to $6.6 million in 2025.
  • Its last three reported values are $6.6 million in Q2 2025, $4.9 million for Q1 2025, and $2.6 million during Q4 2024.